SCHEMBL1659057

SCHEMBL1659057

CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3Cl)c(F)c2)ccn1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 8/20 0.75
KDR P35968 7/20 0.75
RAF1 P04049 7/20 0.75
BRAF P15056 6/20 0.75
ABL1 P00519 4/20 0.75
RET P07949 4/20 0.75
EPHA2 P29317 3/20 0.75
MAP3K20 Q9NYL2 3/20 0.75
RIPK2 O43353 3/20 0.75
EPHX2 P34913 3/20 0.75
ABCB11 O95342 2/20 0.75
HTR1A P08908 2/20 0.75
PDGFRB P09619 2/20 0.75
ADORA3 P0DMS8 2/20 0.75
KIT P10721 2/20 0.75
FGFR1 P11362 2/20 0.75
PDGFRA P16234 2/20 0.75
FLT1 P17948 2/20 0.75
MAOA P21397 2/20 0.75
EPHA1 P21709 2/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1660403 0.92 BRAF (0.68) MAPK14KDRRAF1BRAFABL1
SCHEMBL1660255 0.90 RAF1 (0.79) MAPK14KDRRAF1BRAFABL1
SCHEMBL1662209 0.89 BRAF (0.69) MAPK14KDRRAF1BRAFABL1
SCHEMBL1661876 0.89 MAPK14 (0.71) MAPK14KDRRAF1BRAFABL1
SCHEMBL18191221 0.88 RAF1 (0.76) MAPK14KDRRAF1BRAFABL1
SCHEMBL1658928 0.87 RAF1 (0.69) MAPK14KDRRAF1BRAFABL1
SCHEMBL14911164 0.86 ABL1 (0.73) MAPK14KDRRAF1BRAFABL1
SCHEMBL2332335 0.86 RAF1 (0.61) MAPK14KDRRAF1BRAFABL1
SCHEMBL1661154 0.86 RAF1 (0.68) MAPK14KDRRAF1BRAFABL1
Regorafenib SCHEMBL29351376 0.86 RAF1 (1.00) MAPK14KDRRAF1BRAFABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011046991-A2 CERTAIN SUBSTITUTED UREAS AS MODULATORS OF KINASE ACTIVITY GILEAD CONNECTICUT, INC. (US) 2011-04-21 WO disclosed